Literature DB >> 20881290

Potential novel mechanism for Axenfeld-Rieger syndrome: deletion of a distant region containing regulatory elements of PITX2.

Bethany A Volkmann1, Natalya S Zinkevich, Aki Mustonen, Kala F Schilter, Dmitry V Bosenko, Linda M Reis, Ulrich Broeckel, Brian A Link, Elena V Semina.   

Abstract

PURPOSE: Mutations in PITX2 are associated with Axenfeld-Rieger syndrome (ARS), which involves ocular, dental, and umbilical abnormalities. Identification of cis-regulatory elements of PITX2 is important to better understand the mechanisms of disease.
METHODS: Conserved noncoding elements surrounding PITX2/pitx2 were identified and examined through transgenic analysis in zebrafish; expression pattern was studied by in situ hybridization. Patient samples were screened for deletion/duplication of the PITX2 upstream region using arrays and probes.
RESULTS: Zebrafish pitx2 demonstrates conserved expression during ocular and craniofacial development. Thirteen conserved noncoding sequences positioned within a gene desert as far as 1.1 Mb upstream of the human PITX2 gene were identified; 11 have enhancer activities consistent with pitx2 expression. Ten elements mediated expression in the developing brain, four regions were active during eye formation, and two sequences were associated with craniofacial expression. One region, CE4, located approximately 111 kb upstream of PITX2, directed a complex pattern including expression in the developing eye and craniofacial region, the classic sites affected in ARS. Screening of ARS patients identified an approximately 7600-kb deletion that began 106 to 108 kb upstream of the PITX2 gene, leaving PITX2 intact while removing regulatory elements CE4 to CE13.
CONCLUSIONS: These data suggest the presence of a complex distant regulatory matrix within the gene desert located upstream of PITX2 with an essential role in its activity and provides a possible mechanism for the previous reports of ARS in patients with balanced translocations involving the 4q25 region upstream of PITX2 and the current patient with an upstream deletion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20881290      PMCID: PMC3101680          DOI: 10.1167/iovs.10-6060

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  55 in total

1.  A novel PITX2 mutation and a polymorphism in a 5-generation family with Axenfeld-Rieger anomaly and coexisting Fuchs' endothelial dystrophy.

Authors:  Christoph Kniestedt; Malgorzata Taralczak; Michael A Thiel; Joerg Stuermer; Alessandra Baumer; Balder P Gloor
Journal:  Ophthalmology       Date:  2006-07-31       Impact factor: 12.079

2.  Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.

Authors:  Peter J Mohler; Solena Le Scouarnec; Isabelle Denjoy; John S Lowe; Pascale Guicheney; Lise Caron; Iwona M Driskell; Jean-Jacques Schott; Kris Norris; Antoine Leenhardt; Richard B Kim; Denis Escande; Dan M Roden
Journal:  Circulation       Date:  2007-01-22       Impact factor: 29.690

3.  A novel homeobox mutation in the PITX2 gene in a family with Axenfeld-Rieger syndrome associated with brain, ocular, and dental phenotypes.

Authors:  Faisal Idrees; Agnes Bloch-Zupan; Samantha L Free; Daniela Vaideanu; Pamela J Thompson; Paul Ashley; Glen Brice; Paul Rutland; Maria Bitner-Glindzicz; Peng T Khaw; Scott Fraser; Sanjay M Sisodiya; Jane C Sowden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

4.  Analysis of mutations of the PITX2 transcription factor found in patients with Axenfeld-Rieger syndrome.

Authors:  Tim Footz; Faisal Idrees; Moulinath Acharya; Kathy Kozlowski; Michael A Walter
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-14       Impact factor: 4.799

5.  Impairing retinoic acid signalling in the neural crest cells is sufficient to alter entire eye morphogenesis.

Authors:  Nicolas Matt; Norbert B Ghyselinck; Isabelle Pellerin; Valérie Dupé
Journal:  Dev Biol       Date:  2008-05-11       Impact factor: 3.582

6.  Cytogenetically invisible microdeletions involving PITX2 in Rieger syndrome.

Authors:  E Engenheiro; J Saraiva; I Carreira; L Ramos; H H Ropers; E Silva; N Tommerup; Z Tümer
Journal:  Clin Genet       Date:  2007-09-10       Impact factor: 4.438

7.  Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2.

Authors:  Jinsheng Weng; Jian Luo; Xuhong Cheng; Chang Jin; Xiangtian Zhou; Jia Qu; Lili Tu; Di Ai; Dali Li; Jun Wang; James F Martin; Brad A Amendt; Mingyao Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-18       Impact factor: 11.205

8.  Morphology of the sella turcica in Axenfeld-Rieger syndrome with PITX2 mutation.

Authors:  P Meyer-Marcotty; N Weisschuh; P Dressler; J Hartmann; A Stellzig-Eisenhauer
Journal:  J Oral Pathol Med       Date:  2008-03-10       Impact factor: 4.253

9.  Nuclear factor 1 and T-cell factor/LEF recognition elements regulate Pitx2 transcription in pituitary development.

Authors:  Di Ai; Jun Wang; Melanie Amen; Mei-Fang Lu; Brad A Amendt; James F Martin
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

10.  PITX2 gain-of-function induced defects in mouse forelimb development.

Authors:  Johan Holmberg; Gorel Ingner; Curt Johansson; Peter Leander; Tord A Hjalt
Journal:  BMC Dev Biol       Date:  2008-02-29       Impact factor: 1.978

View more
  20 in total

1.  Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes.

Authors:  E Weh; L M Reis; R C Tyler; D Bick; W J Rhead; S Wallace; T L McGregor; S K Dills; M-C Chao; J C Murray; E V Semina
Journal:  Clin Genet       Date:  2013-09-17       Impact factor: 4.438

Review 2.  Eukaryotic enhancers: common features, regulation, and participation in diseases.

Authors:  Maksim Erokhin; Yegor Vassetzky; Pavel Georgiev; Darya Chetverina
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

Review 3.  Genetics of anterior segment dysgenesis disorders.

Authors:  Linda M Reis; Elena V Semina
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

Review 4.  Common and rare genetic risk factors for glaucoma.

Authors:  Ryan Wang; Janey L Wiggs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-18       Impact factor: 6.915

5.  Mutations of conserved non-coding elements of PITX2 in patients with ocular dysgenesis and developmental glaucoma.

Authors:  Meredith E Protas; Eric Weh; Tim Footz; Jay Kasberger; Scott C Baraban; Alex V Levin; L Jay Katz; Robert Ritch; Michael A Walter; Elena V Semina; Douglas B Gould
Journal:  Hum Mol Genet       Date:  2017-09-15       Impact factor: 6.150

Review 6.  Enhancers: bridging the gap between gene control and human disease.

Authors:  Jaret M Karnuta; Peter C Scacheri
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

Review 7.  Genetics of Primary Inherited Disorders of the Optic Nerve: Clinical Applications.

Authors:  Keri F Allen; Eric D Gaier; Janey L Wiggs
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

Review 8.  Relationship between neural crest cell specification and rare ocular diseases.

Authors:  Monica Akula; Jeong Won Park; Judith A West-Mays
Journal:  J Neurosci Res       Date:  2018-04-16       Impact factor: 4.164

9.  PITX2 is involved in stress response in cultured human trabecular meshwork cells through regulation of SLC13A3.

Authors:  M Hermina Strungaru; Tim Footz; Yi Liu; Fred B Berry; Pascal Belleau; Elena V Semina; Vincent Raymond; Michael A Walter
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

10.  Chromatin Architecture of the Pitx2 Locus Requires CTCF- and Pitx2-Dependent Asymmetry that Mirrors Embryonic Gut Laterality.

Authors:  Ian C Welsh; Hojoong Kwak; Frances L Chen; Melissa Werner; Lindsay S Shopland; Charles G Danko; John T Lis; Min Zhang; James F Martin; Natasza A Kurpios
Journal:  Cell Rep       Date:  2015-09-24       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.